ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bush, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bush, A.
Eur Respir J 2007; 29:822
Copyright ©ERS Journals Ltd 2007

From the author

A. Bush

Royal Brompton Hospital, London, UK.

I would like thank A. Gammelgaard and H. Bisgaard for their interest in my Editorial 1. They welcome the European Union initiative and rightly highlight that more than just money and infrastructure is needed to achieve successful clinical trials in children. As they say, ethical issues are paramount, relatively poorly studied in children and should be the subject of further work. There is also a paucity of data about how best to make trials work on a day-to-day basis, as recently discussed 2. Indeed, the surest way of making a paediatric trial a failure is to take an adult protocol, change the word "adult" to "child" throughout with the word processor and attempt to make the trial work. It will not.

It is to be hoped that all these very important paediatric clinical trial issues, ethical, organisational and practical, can be developed through the Seventh Framework Programme (FP7) for research, so that the needs and expectations of Europe's most vulnerable community, small children, can be addressed, leading to truly evidence-based therapeutics.

REFERENCES

  1. Bush A. Evidence-based medicines for children: important implications for new therapies at all ages. Eur Respir J 2006;28:1069–1072.[Free Full Text]
  2. Bush A. Clinical trials research in pediatrics. Strategies for effective collaboration between investigator sites and the pharmaceutical industry. Pediatr Drugs 2006;8:271–277.[CrossRef]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bush, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bush, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS